2014 California Children’s Report Card
Published Date: August 28, 2017

​A randomized clinical trial of 377 primary care patients with opioid and/or alcohol use disorders (OAUD) was conducted in 2 clinics in a federally qualified health center to determine whether collaborative care (CC) for OAUD improves delivery of evidence-based treatments for OAUD and increases self-reported abstinence compared with usual primary care. Collaborative care was a system-level intervention, designed to increase the delivery of either a 6-session brief psychotherapy treatment and/or medication-assisted treatment with either sublingual buprenorphine/naloxone for opioid use disorders or long-acting injectable naltrexone for alcohol use disorders. Usual care participants were told that the clinic provided OAUD treatment and given a number for appointment scheduling and list of community referrals.

After 6 months, the proportion of participants who received any OAUD treatment was higher in the CC group compared with usual care (39.0% vs. 16.8%); A higher proportion of CC participants reported abstinence from opioids or alcohol at 6 months (32.8% vs 22.3%). In secondary analyses, the proportion meeting the Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement measures was also higher among CC participants (initiation, 31.6% vs 13.7%; engagement, 15.5% vs 4.2%) as was abstinence from opioids, cocaine, methamphetamines, marijuana, and any alcohol (26.3% vs 15.6%). The study was conducted by the RAND.



Publication Authors:
  • Katherine E. Watkins
  • Allison J. Ober
  • Karen Lamp
  • Allison L. Diamant, MD, MSHS
  • et al
View Publication
Authors
Allison L. Diamant, MD, MSHS